[Experience with clinical trials of the new anti-influenza drug rimantadine].
D000218:Adamantane / Q000031:analogs & derivatives*; D000998:Antiviral Agents / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D007773:Lactates / Q000627:therapeutic use; D012189:Retrospective Studies; D012299:Rimantadine / Q000627:therapeutic use*; D012431:Rutin / Q000627:therapeutic use
D000998:Antiviral Agents; D004338:Drug Combinations; D007773:Lactates; D012299:Rimantadine; D012431:Rutin; C012184:antigrippen; D004155:Diphenhydramine; D000218:Adamantane; D001205:Ascorbic Acid; D001241:Aspirin
Opyt klinicheskogo izucheniia protivogrippoznogo preparata remantadina.